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Abstract
Introduction: The granulocyte-colony stimulating factor-producing tumor was first reported in
1977, however, anaplastic pleomorphic type carcinoma of the pancreas producing granulocyte-
colony stimulating factor is still rare.
Case presentation: A 63-year-old man was admitted to our hospital with body weight loss (-10
kg during months) and upper abdominal pain from 3 weeks. Abdominal computed tomography
demonstrated a pancreatic tumor 10 cm in size and multiple low-density areas in the liver. On
admission, the peripheral leukocyte count was elevated to 91,500/mm3  and the serum
concentration of granulocyte-colony stimulating factor was 134 pg/mL (normal, < 18.1 pg/mL).
Based on liver biopsy findings, the tumor was classified as an anaplastic pleomorphic-type
carcinoma. Immunohistochemical staining showed that pancreatic carcinoma cells were positive for
granulocyte-colony stimulating factor. The patient developed interstitial pneumonia, probably
caused by granulocyte-colony stimulating factor, and died 11 days after admission.
Conclusion: This is a rare case report of anaplastic pleomorphic-type carcinoma of the pancreas
producing granulocyte-colony stimulating factor and confirmed by immunohistochemistry.
Introduction
The granulocyte-colony stimulating factor (G-CSF)-pro-
ducing tumor was first reported in 1977 by Asano et al. in
lung cancer [1]. Since that study, further G-CSF-producing
lung carcinomas have been reported, but G-CSF-produc-
ing pancreatic carcinomas have been very rare [2-7].
Moreover, there have been only a few cases which have
reported positive immunostaining for G-CSF in cancer
cells [6,7]. We present a case of an anaplastic pancreatic
carcinoma with G-CSF production that was confirmed
with immunohistochemistry.
Case presentation
A 63-year-old man was admitted to our hospital with
body weight loss (-10 kg during 6 months) and upper
abdominal pain. His blood pressure was 123/71 mmHg,
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pulse was 92 bpm. Physical examination revealed upper
left quadrant pain but soft in his abdomen. The tumor
was palpable in the upper left abdomen.
Laboratory examination findings were as follows: Periph-
eral leukocyte count was 91,500/mm3  (87.5% neu-
trophils, 0% eosinophils, 1.5% lymphocytes, 1%
monocytes), hemoglobin was 10.3 g/dL, and platelet
count was 38.3 × 104/mm3. Serum pancreatic enzymes
such as amylase, lipase, and elastase-1 were normal.
Serum tumor markers such as sIL-2R (soluble interleukin-
2 receptor) and TK (thymidine kinase) were elevated to
2870 U/ml and 15 U/L, respectively, but CEA (Carci-
noembryonic Antigen), CA 19-9 (Carbohydrate Antigen
19-9) and NSE (Neuron-specific enolase) were normal.
The serum G-CSF was elevated to 134 pg/mL (normal, <
18.1 pg/mL, by enzyme immunoassay).
Computed tomography (CT) showed a heterogeneously
enhanced mass 10 cm in diameter in the left upper abdo-
men and multiple low density areas in the liver (see Figure
1). The pancreas could not be detected and it is suggested
that the large tumor was originally derived from the pan-
creas. Magnetic resonance imaging showed a mass of het-
erogeneous intensity on both T1- and T2-weighted
images. Endoscopic examination revealed an extrinsic
compression 10 cm in size, at the lesser curve of the body
of the stomach. In 2-deoxy-2-[18F]-fluoro-D-glucose pos-
itron emission tomography (PET), the maximum stand-
ardized uptake value was over 11 at his left upper
abdominal lesion. No source of infection was detected.
We therefore speculated that this case might be a G-CSF-
producing pancreatic carcinoma.
Following informed consent, a tumor biopsy of the liver
was performed. Histopathologic diagnosis of the tumor
was an anaplastic pleomorphic-type carcinoma (see Fig-
ure 2). Immunohistochemical staining of formalin-fixed
paraffin-embedded liver biopsy material was performed.
The pancreatic cancer cells were positive for G-CSF (see
Figure 3).
The patient developed interstitial pneumonia, probably
caused by G-CSF produced by the carcinoma, and died 11
days after admission.
Discussion
In 1977, Asano et al. [1] reported a case of G-CSF-produc-
ing lung cancer. Since then, G-CSF-producing tumors
have been reported, however, most cases were of lung can-
cer origin and G-CSF-producing pancreatic cancer is very
rare [2-7].
In the present case, the peripheral leukocyte count was
markedly elevated (91,500/mm3) on admission, how-
ever, no source of infection was detected. Serum G-CSF
was elevated to 134 pg/mL. In the liver biopsy material,
the histology was anaplastic pleomorphic-type carcinoma
and G-CSF was positive on immunohistochemical stain-
ing, so we considered that this tumor produced G-CSF. It
is uncommon for G-CSF production to be successfully
demonstrated with immunohistochemical staining
[4,6,7].
Anaplastic carcinoma of the pancreas, also called undiffer-
entiated carcinoma, giant cell carcinoma, pleomorphic
large cell carcinoma or sarcomatoid carcinoma, is not
common. The incidence of the tumor is only about 2% to
7% of all pancreatic cancers [8-11]. Anaplastic carcinoma
Computed tomography showed an unevenly enhanced mass  10 cm in diameter in the patient's left upper abdomen Figure 1
Computed tomography showed an unevenly enhanced mass 
10 cm in diameter in the patient's left upper abdomen.
Histopathologic diagnosis of the tumor was an anaplastic ple- omorphic-type carcinoma (hematoxylin and eosin stain;  ×100) Figure 2
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has also been rarely identified as a G-CSF-producing
tumor [5].
G-CSF-producing tumors are considered to indicate a
poor prognosis [2]. In G-CSF-producing lung cancer, large
cell tumors and squamous cell tumors are dominant [2].
The 5-year survival rate of large cell tumors is only 14.0%
[12]. In addition, Uematsu et al. [3] reported that histo-
logic examination of G-CSF-producing carcinomas usu-
ally reveals poorly differentiated cells, and moreover, the
tumors exhibit rapid growth and are associated with a
poor prognosis.
The prognosis of G-CSF-producing carcinomas of the pan-
creas is also poor. Ohtsubo et al., Kawakami et al., Goto-
hda et al., Fukushima et al., and our case showed that the
survival from tumor detection to death ranged from 11 to
135 days, with a mean of 81.2 days [4-7].
The patient developed interstitial pneumonia and died 11
days after admission. Why did interstitial pneumonia
develop? Cases of interstitial pneumonia secondary to
treatment with G-CSF have been reported [13]. G-CSF
stimulates neutrophils and macrophages. Cytotoxic
superoxide from neutrophils and various growth factors
from macrophages cause interstitial pneumonia [13]. An
increased serum G-CSF level and interstitial pneumonia
may be reasons for poor prognosis in patients with G-CSF-
producing tumors as in our case.
Conclusion
This is a rare case report of an anaplastic pleomorphic-
type carcinoma of the pancreas producing granulocyte-
colony stimulating factor, and confirmed with immuno-
histochemistry. The clinical characteristics of this disease
are still unclear and further detailed studies should be per-
formed.
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